131 related articles for article (PubMed ID: 21224508)
1. The S140G KCNQ1 atrial fibrillation mutation affects 'I(KS)' profile during both atrial and ventricular action potentials.
El Harchi A; Zhang H; Hancox JC
J Physiol Pharmacol; 2010 Dec; 61(6):759-64. PubMed ID: 21224508
[TBL] [Abstract][Full Text] [Related]
2. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation.
Campbell CM; Campbell JD; Thompson CH; Galimberti ES; Darbar D; Vanoye CG; George AL
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):960-6. PubMed ID: 24006450
[TBL] [Abstract][Full Text] [Related]
4. A novel KCNQ1 missense mutation identified in a patient with juvenile-onset atrial fibrillation causes constitutively open IKs channels.
Hasegawa K; Ohno S; Ashihara T; Itoh H; Ding WG; Toyoda F; Makiyama T; Aoki H; Nakamura Y; Delisle BP; Matsuura H; Horie M
Heart Rhythm; 2014 Jan; 11(1):67-75. PubMed ID: 24096004
[TBL] [Abstract][Full Text] [Related]
5. In silico investigation of a KCNQ1 mutation associated with familial atrial fibrillation.
Hancox JC; Kharche S; El Harchi A; Stott J; Law P; Zhang H
J Electrocardiol; 2014; 47(2):158-65. PubMed ID: 24411289
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation in KCNE1-null mice.
Temple J; Frias P; Rottman J; Yang T; Wu Y; Verheijck EE; Zhang W; Siprachanh C; Kanki H; Atkinson JB; King P; Anderson ME; Kupershmidt S; Roden DM
Circ Res; 2005 Jul; 97(1):62-9. PubMed ID: 15947250
[TBL] [Abstract][Full Text] [Related]
7. Pro-arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation - insights from modelling.
Kharche S; Adeniran I; Stott J; Law P; Boyett MR; Hancox JC; Zhang H
J Physiol; 2012 Sep; 590(18):4501-14. PubMed ID: 22508963
[TBL] [Abstract][Full Text] [Related]
8. KCNQ1 gain-of-function mutation in familial atrial fibrillation.
Chen YH; Xu SJ; Bendahhou S; Wang XL; Wang Y; Xu WY; Jin HW; Sun H; Su XY; Zhuang QN; Yang YQ; Li YB; Liu Y; Xu HJ; Li XF; Ma N; Mou CP; Chen Z; Barhanin J; Huang W
Science; 2003 Jan; 299(5604):251-4. PubMed ID: 12522251
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.
Shamgar L; Ma L; Schmitt N; Haitin Y; Peretz A; Wiener R; Hirsch J; Pongs O; Attali B
Circ Res; 2006 Apr; 98(8):1055-63. PubMed ID: 16556865
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels.
Restier L; Cheng L; Sanguinetti MC
J Physiol; 2008 Sep; 586(17):4179-91. PubMed ID: 18599533
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.
McPate MJ; Zhang H; Adeniran I; Cordeiro JM; Witchel HJ; Hancox JC
J Physiol Pharmacol; 2009 Mar; 60(1):23-41. PubMed ID: 19439805
[TBL] [Abstract][Full Text] [Related]
12. Modulation of KCNQ1 current by atrial fibrillation-associated KCNE4 (145E/D) gene polymorphism.
Ma KJ; Li N; Teng SY; Zhang YH; Sun Q; Gu DF; Pu JL
Chin Med J (Engl); 2007 Jan; 120(2):150-4. PubMed ID: 17335661
[TBL] [Abstract][Full Text] [Related]
13. Gating mechanisms underlying deactivation slowing by two KCNQ1 atrial fibrillation mutations.
Peng G; Barro-Soria R; Sampson KJ; Larsson HP; Kass RS
Sci Rep; 2017 Apr; 7():45911. PubMed ID: 28383569
[TBL] [Abstract][Full Text] [Related]
14. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
[TBL] [Abstract][Full Text] [Related]
15. Characterization of KCNQ1 atrial fibrillation mutations reveals distinct dependence on KCNE1.
Chan PJ; Osteen JD; Xiong D; Bohnen MS; Doshi D; Sampson KJ; Marx SO; Karlin A; Kass RS
J Gen Physiol; 2012 Feb; 139(2):135-44. PubMed ID: 22250012
[TBL] [Abstract][Full Text] [Related]
16. Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation?
Otway R; Vandenberg JI; Guo G; Varghese A; Castro ML; Liu J; Zhao J; Bursill JA; Wyse KR; Crotty H; Baddeley O; Walker B; Kuchar D; Thorburn C; Fatkin D
J Am Coll Cardiol; 2007 Feb; 49(5):578-86. PubMed ID: 17276182
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of a KCNQ1 mutation associated with the long QT syndrome.
Boulet IR; Raes AL; Ottschytsch N; Snyders DJ
Cardiovasc Res; 2006 Jun; 70(3):466-74. PubMed ID: 16564513
[TBL] [Abstract][Full Text] [Related]
18. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
[TBL] [Abstract][Full Text] [Related]
19. Alteration of HERG current profile during the cardiac ventricular action potential, following a pore mutation.
Hancox JC; Witchel HJ; Varghese A
Biochem Biophys Res Commun; 1998 Dec; 253(3):719-24. PubMed ID: 9918793
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).
Gómez R; Núñez L; Vaquero M; Amorós I; Barana A; de Prada T; Macaya C; Maroto L; Rodríguez E; Caballero R; López-Farré A; Tamargo J; Delpón E
Cardiovasc Res; 2008 Dec; 80(3):375-84. PubMed ID: 18678642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
